Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Tag: Osteonecrosis
CITTA Brings Modern Science to an Indian Soul – Time to Reclaim Our Skincare
They Took Our Haldi, Sold It Back to Us… / Colonialism Ended. But We Still Don’t Trust Our Own Remedies...
Read more
